Clinical aspects of epicardial fat deposition

Česká verzia

Authors: Markéta Sovová
Authors place of work: Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace LF UP a FN Olomouc
Published in the journal: Vnitř Lék 2020; 66(2): 42-46
Category:

Summary

Obesity is a chronic metabolic disease which is characterized by an increased body fat. Obesity increases cardiovascular morbidity and mortality and presents an important socioeconomic burden for the health system. So-called “central-android-abdominal-visceral” obesity plays an important role in the development of cardiovascular diseases. Adipose tissue is nowadays considered to be metabolically active tissue which is involved in many metabolic processes, managing food intake, lipid metabolism regulation, and also inflammatory diseases. Many cytokines, such as those regulating body temperature, are produced by the adipose tissue. In the last few years, many studies of ectopic adipose tissue including epicardial fat were published. This is a complex organ which consists of adipocytes, stromal cells, macrophages, and network of neural cells and blood capillaries. This thesis summarizes updated information regarding physiological and pathophysiological role of epicardial fat, epicardial fat measurement and a possible connection with common diseases, such as ischemic heart disease, cardiac arrhythmias, diabetes mellitus, chronic obstructive pulmonary disease and disease of thyroid gland.

Keywords:

obesity – metabolic syndrome – arrhythmias – coronary heart disease – diabetes mellitus – epicardial fat – chronic obstructive pulmonary disease

Zdroje

1. Britton KA, Massaro JM, Murabito JM, et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013; 62: 921–925.

2. Pischon T, Boeing H, Hoffmann KG, et al. General and abdominal obezity and risk of death in Europe. NEJM 2008; 359: 2105–2120.

3. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation 2011; 124: 837–841.

4. Iozzo P. Myocardial, perivascular and epicardial fat. Diabetes Care 2011; 34: 371–379.

5. Bertaso AG, Bertol D, Duncan BB, et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol 2013; 101: e18–e28.

6. Antonopoulos AS, Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol 2017; 595: 3907–3919.

7. Nagy E, Jermendy AL, Merkely B, et al. Clinical importance of epicardial adipose tissue. Arch Med Sci 2017; 13: 864–874.

8. Ding J, Hsu FC, Harris TB, et al. The association of pericardial fat with incident coronary heart disease: The Multi- Ethnic Study of Atherosclerosis (MESA) Am Clin Nutr 2009; 90: 499–504.

9. Alexopoulos N, McLean DS, Janik M, et al. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010; 210: 150–154.

10. Hirata Y, Yamada H, Sata M. Epicardial fat and pericardial fat surrouning the heart have different characteristics. Circ J doi:10.1253/circ.CJ-18-0923

11. Miyazawa I, Ohkubo T, Kadowaki S, et al. Change in pericardial fat volume and cardiovascular risk faktors in a general population of Japanese men. Circ J. doi:10.1253/circ.CJ-18-0153

12. Mahabadi AA, Berg MH, Lehmann N, et al Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol 2013; 61: 1388–1395.

13. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009; 22: 1311–1319.

14. Fox CS, Gona P, Hoffmann U, et al. Pericardial fat, intrathoracic fat and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 2009; 119: 1586–1591.

15. Gorter PM, van Lindert AS, de Vos AM, et al. Quantification of epicardial fat and pericoronary fat using cardiac computer tomography; reproducibility and relation with obezity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008; 197: 896–903.

16. Willens HJ, Gómez-Marín O, Chirinos JA, et al. Comparison of epicardial and pericardial fat thiskness assessed by echocardiography in African American and non-Hispanic white man: a pilot study. Ethn Dis 2008; 18: 311–316.

17. Pierdomenico SD, Pierdomenico AM, Cuccurullo F, et al. Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. AM J Cardiol 2013; 111: 73–78.

18. Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord 2014; 12: 31–42.

19. Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinology 2009; 70: 876–882.

20. Darabian S, Backlund JY, Cleary PA, et al. Significance of epicardial and intrathoracic adipose tissue volume among type 1 diabetes patients in the DCCT/EDIC: a pilot study. PLoS One 2016; 11: e0159958.

21. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community based sample: the Framingham Heart Study. Circulation 2008; 117: 605–613.

22. Cheng VY, Dey D, Tamarappoo B, et al. Pericardial fat burden on ECG gated noncontrast CT in asymptomatic patients who susequently experience adverse cardiovascular events. JACC Cardiovasc Imaging 2010; 3: 352–360.

23. Wu FZ, Chou JK, Huang YL, et al. The relation of location-specific epicardial adipose tissue thickness and obstructive coronary artery disease: systemic review and meta-analysis of observational studies. BMC 2014; 14: 62.

24. Prídavková D, Kantárová D, Lišková R, et al. Význam epikardiálního tuku a obezitních parametrů při predikcii koronárnej choroby srdca. Vnitř Lék 2016; 62: 256–262.

25. Abed HS, Samuel CS, Lau DH, et al. Obezity results in progressive atrial structural and electrical remodeling implication for atrial fibrilation. Heart Rhythm 2013; 10: 90–100.

26. Acet H, Ertas F, Akai MA, et al. New inflammatory prediction for non-valvular atrial fibrilation: echocardiographic epicardial fat thickness and neutrophil to lymfocyte ratio. Int J Cardiovasc Imaging 2014; 30: 81–89.

27. Nakamori S, Nezafat M, Ngo LH, et al. Left epicardial fat volum eis associated with atrial fibrillation: a prospective cardiovascular magnetic resonance 3D Dixon Study. J Am Heart Assoc 2018; 7: e008232.

28. Cho KI, Kim BJ, Cho SH, et al. Epicardial fat thickness and free fatty acid level are predictors of acute ischemic stroke with atrial fibrilation. J Cardiovasc Imaging 2018; 26: 65–74.

29. Anumonwo JMB, Herron T. Fatty infiltration of the myocardium and arrhythmogenesis: potential cellular and molecular mechanisms. Front Physiol 2018; 9: article 2.

30. Aydogdu A, Karakas E Y, Erkus E, et al. Epicardial fat thickness and oxidative stress parameters in patients with subclinical hypothyreoidism. Arch Med Sci 2017; 13: 383–389.

31. Zagaceta J, Zulueta JJ, Bastarrika G, et al. Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease. http://doi.org/10.1371/journal.pone.0065593

32. Kiraz K, Gokdeniz T, Kalaycioglu E, et al. Epicardial fat thickness is associated with severity of disease in patient with chronic obstructive pulmonary disease. European Review for Medical and Pharmacological Sciences 2016, 20: 4508-4515.

33. Rabkin SW, Campbell H. Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta- analysis. Obes Rev 2015; 16: 406–415.

34. Ismail I, Keating SE, Baker MK, et al. A systematic review and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral fat. Obes Rev 2012; 13: 68–91.

35. Park JH, Park YS, Kim YJ, et al. Effects of statins in the epicardial fat thickness in patients with coronary artery stenosis underwent percutaeneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound 2010; 18: 121–126.

36. Sato T, Aizawa Y, Yuasa S et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol 2018; 17: 6.

37. Lima-Martínez MM, Paoli M, Rodney M, et al. Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study. Endocrine 2016; 51: 448–455.

38. Iacobellis G, Mohseni M, Bianco SD, et al. Liraglutide causes large and rapid epicardial fat reduction. Obesity (Silver Spring) 2017; 25: 311–316.